Achieve Life Sciences (ACHV) Short Interest Ratio & Short Volume $2.26 +0.03 (+1.35%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Achieve Life Sciences Short Interest DataAchieve Life Sciences (ACHV) has a short interest of 2.97 million shares, representing 8.83% of the float (the number of shares available for trading by the public). This marks a 13.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.8, indicating that it would take 11.8 days of the average trading volume of 249,357 shares to cover all short positions.Current Short Interest2,970,000 sharesPrevious Short Interest2,620,000 sharesChange Vs. Previous Month+13.36%Dollar Volume Sold Short$9.65 millionShort Interest Ratio11.8 Days to CoverLast Record DateJune 15, 2025Outstanding Shares34,690,000 sharesShort Percent of Float8.83%Today's Trading Volume2,627,586 sharesAverage Trading Volume249,357 sharesToday's Volume Vs. Average1,054% Short Selling Achieve Life Sciences? Sign up to receive the latest short interest report for Achieve Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACHV Short Interest Over TimeACHV Days to Cover Over TimeACHV Percentage of Float Shorted Over Time Achieve Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20252,970,000 shares $9.65 million +13.4%8.8%11.8 $3.25 5/31/20252,620,000 shares $9.14 million -0.8%7.8%11.2 $3.49 5/15/20252,640,000 shares $7.21 million +4.4%7.8%13.4 $2.73 4/30/20252,530,000 shares $6.58 million +1.2%N/A13.3 $2.60 4/15/20252,500,000 shares $5.40 million -12.9%7.4%11.9 $2.16 3/31/20252,870,000 shares $7.66 million -5.3%8.5%11.9 $2.67 3/15/20253,030,000 shares $8.36 million -3.8%9.0%12.8 $2.76 2/28/20253,150,000 shares $9.67 million -2.5%9.3%13.9 $3.07 2/15/20253,230,000 shares $11.05 million +11.4%9.6%14.8 $3.42 1/31/20252,900,000 shares $9.48 million -24.7%N/A13.2 $3.27 Get the Latest News and Ratings for ACHV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20253,850,000 shares $12.63 million +1.1%N/A20.6 $3.28 12/31/20243,810,000 shares $13.41 million +30.0%N/A24.8 $3.52 12/15/20242,930,000 shares $12.01 million +2.5%N/A23.7 $4.10 11/30/20242,860,000 shares $12.61 million -4.7%N/A26.4 $4.41 11/15/20243,000,000 shares $12.75 million -9.6%N/A27.9 $4.25 10/31/20243,320,000 shares $15.54 million +1.2%N/A33.1 $4.68 10/15/20243,280,000 shares $16.42 million +3.8%N/A29.8 $5.01 9/30/20243,160,000 shares $14.98 million No ChangeN/A25.6 $4.74 9/15/20243,160,000 shares $14.31 million +4.6%N/A15.3 $4.53 8/31/20243,020,000 shares $13.26 million +1.3%N/A13.2 $4.39 8/15/20242,980,000 shares $13.26 million +9.6%N/A12.4 $4.45 7/31/20242,720,000 shares $13.55 million +12.9%N/A11 $4.98 7/15/20242,410,000 shares $11.93 million +58.6%N/A10.3 $4.95 6/30/20241,520,000 shares $7.14 million +35.7%N/A7 $4.70 6/15/20241,120,000 shares $5.49 million +17.9%N/A8.4 $4.90 5/31/2024949,700 shares $4.96 million +26.5%N/A8.2 $5.22 5/15/2024750,500 shares $3.91 million +2.6%N/A6.2 $5.21 4/30/2024731,700 shares $3.21 million +2.6%N/A7.2 $4.39 4/15/2024713,300 shares $3.17 million -0.6%N/A7.6 $4.45 3/31/2024717,500 shares $3.26 million +2.2%N/A7.6 $4.55 3/15/2024701,800 shares $3.22 million +9.1%N/A7.6 $4.59 2/29/2024643,200 shares $2.60 million -3.6%N/A5.8 $4.05 2/15/2024667,200 shares $2.98 million -0.7%N/A7.8 $4.47 1/31/2024671,900 shares $3.31 million +1.5%N/A7.7 $4.93 1/15/2024661,900 shares $2.84 million -1.5%N/A8.1 $4.29 12/31/2023671,800 shares $2.77 million -5.0%N/A8.5 $4.12 12/15/2023707,200 shares $2.25 million +3.0%N/A9 $3.18 11/30/2023686,600 shares $3.98 million 0.0%N/A18.2 $5.79 11/15/2023686,700 shares $3.34 million -1.4%N/A16.7 $4.86 10/31/2023696,400 shares $2.80 million +0.5%N/A16.8 $4.02A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 10/15/2023693,300 shares $2.58 million -1.7%N/A15.2 $3.72 9/30/2023705,300 shares $3.03 million +0.7%N/A14.3 $4.30 9/15/2023700,700 shares $3.25 million -2.6%N/A12.2 $4.64 8/31/2023719,200 shares $3.57 million -1.3%N/A10.5 $4.96 8/15/2023728,300 shares $3.78 million -2.6%N/A5.9 $5.19 7/31/2023748,000 shares $4.19 million -7.4%N/A5.3 $5.60 7/15/2023807,600 shares $4.30 million +0.6%N/A5 $5.32 6/30/2023803,100 shares $4.17 million -0.6%N/A4.7 $5.19 6/15/2023808,100 shares $4.77 million +1.2%N/A4.3 $5.90 5/31/2023798,300 shares $4.95 million +26.1%N/A4.3 $6.20 5/15/2023633,200 shares $4.96 million +11.2%N/A4.1 $7.84 4/30/2023569,600 shares $4.74 million +3.7%N/A4.5 $8.33 4/15/2023549,500 shares $3.98 million +0.6%N/A4.5 $7.25 3/31/2023546,400 shares $3.72 million -2.8%N/A4.4 $6.80 3/15/2023562,200 shares $2.56 million -2.0%N/A5.5 $4.56 2/28/2023573,900 shares $2.78 million -9.2%9.4%6.4 $4.85 2/15/2023632,100 shares $3.10 million +5.4%10.3%6.2 $4.90 1/31/2023599,700 shares $2.91 million -37.9%9.8%5.9 $4.86 1/15/2023966,400 shares $4.14 million +13.3%15.7%10.2 $4.28 12/30/2022852,900 shares $2.09 million +12.0%13.9%11.2 $2.45 12/15/2022761,800 shares $1.90 million +2.3%12.4%11.6 $2.50 11/30/2022744,800 shares $2.09 million +122.9%12.1%12.3 $2.80 11/15/2022334,100 shares $775.11 thousand +11.7%5.4%5.5 $2.32 10/31/2022299,200 shares $661.23 thousand -3.1%N/A6.3 $2.21 10/15/2022308,900 shares $837.12 thousand -1.3%N/A6.8 $2.71 9/30/2022313,000 shares $1.03 million -5.0%N/A7.5 $3.30 9/15/2022329,300 shares $1.50 million +0.0%N/A7.6 $4.56 8/31/2022329,200 shares $1.50 million +3.8%N/A7.5 $4.56 8/15/2022317,300 shares $1.79 million +3.1%N/A7.3 $5.64 7/31/2022307,800 shares $1.55 million -3.0%N/A10.1 $5.05 7/15/2022317,200 shares $1.68 million -4.4%N/A4 $5.31 6/30/2022331,800 shares $1.62 million -6.1%N/A4 $4.88 6/15/2022353,500 shares $2.13 million -2.8%N/A4.2 $6.03 5/31/2022363,600 shares $2.51 million -4.3%N/A4.2 $6.90 5/15/2022379,900 shares $2.52 million -11.0%N/A4.4 $6.64 4/30/2022426,700 shares $2.96 million +36.7%N/A5 $6.93 4/15/2022312,200 shares $2.39 million -3.1%N/A7.8 $7.64 3/31/2022322,100 shares $2.44 million -5.0%N/A8.2 $7.57 3/15/2022338,900 shares $2.15 million -6.7%N/A7.7 $6.35 2/28/2022363,400 shares $2.69 million -6.8%N/A7.5 $7.40 2/15/2022389,700 shares $2.99 million -5.7%N/A7.9 $7.66 1/31/2022413,400 shares $3.02 million -2.5%N/A7.5 $7.30 1/15/2022423,800 shares $3.55 million +5.7%N/A7.4 $8.37 12/31/2021401,000 shares $3.12 million -2.7%N/A6.9 $7.78 12/15/2021412,100 shares $2.93 million +2.2%N/A5.8 $7.10 11/30/2021403,400 shares $2.90 million -8.6%N/A5.5 $7.20 11/15/2021441,300 shares $3.57 million +2.5%N/A5.4 $8.10 10/29/2021430,400 shares $3.57 million -6.3%N/A3.7 $8.29 10/15/2021459,300 shares $3.70 million -8.5%N/A3.9 $8.05 9/30/2021502,000 shares $4.27 million +1.1%N/A3.5 $8.50A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 9/15/2021496,400 shares $4.04 million -3.1%N/A2.6 $8.13 8/31/2021512,200 shares $4.28 million -5.3%N/A2.3 $8.35 8/13/2021541,100 shares $3.94 million +2.4%N/A2 $7.28 7/30/2021528,600 shares $3.86 million +7.5%6.1%2.2 $7.31 7/15/2021491,600 shares $3.75 million +26.1%5.6%2.1 $7.63 6/30/2021389,800 shares $3.50 million +22.0%4.5%1.8 $8.98 6/15/2021319,400 shares $2.77 million -3.3%3.7%2.1 $8.68 5/28/2021330,200 shares $2.64 million -22.9%3.8%2.7 $8.01 5/14/2021428,100 shares $3.85 million No Change7.3%3.6 $9.00 4/30/2021428,100 shares $4.73 million -8.6%7.3%4 $11.06 4/15/2021468,600 shares $4.92 million +2.1%8.0%2.9 $10.49 3/31/2021458,900 shares $4.98 million +5.1%7.9%1.7 $10.85 3/15/2021436,500 shares $5.09 million +2.1%7.5%1.5 $11.65 2/26/2021427,600 shares $5.23 million -7.0%12.5%1.3 $12.22 2/12/2021459,800 shares $6.69 million -0.2%13.4%1.4 $14.55 1/29/2021460,500 shares $5.33 million +4.5%14.3%1.2 $11.58 1/15/2021440,800 shares $4.01 million -8.7%13.7%1.3 $9.09 12/31/2020482,600 shares $3.96 million -3.0%14.9%2.3 $8.20 12/15/2020497,400 shares $3.91 million -6.0%15.2%2.5 $7.86 11/30/2020529,000 shares $4.81 million -2.0%14.7%2.2 $9.10 11/15/2020539,700 shares $5.24 million -5.2%15.0%2.6 $9.71 10/30/2020569,300 shares $4.65 million +4.3%16.0%3 $8.17 10/15/2020546,000 shares $4.87 million -3.2%15.3%1.1 $8.92 9/30/2020563,900 shares $4.72 million +7.0%24.6%1 $8.37 9/15/2020527,100 shares $5.22 million +4.3%23.0%0.9 $9.90 8/31/2020505,500 shares $4.13 million +25.8%22.1%1 $8.17 8/14/2020401,800 shares $3.68 million +39.4%17.6%0.8 $9.17 7/31/2020288,200 shares $3.93 million -90.7%N/A0.6 $13.63 7/15/20203,110,000 shares $24.14 million +42.7%N/A1.3 $7.76 6/30/20202,180,000 shares $17.31 million -0.9%N/A1.6 $7.94 ACHV Short Interest - Frequently Asked Questions What is Achieve Life Sciences' current short interest? Short interest is the volume of Achieve Life Sciences shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 2,970,000 shares of ACHV short. 8.83% of Achieve Life Sciences' shares are currently sold short. Learn More on Achieve Life Sciences' current short interest. What is a good short interest ratio for Achieve Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ACHV shares currently have a short interest ratio of 12.0. Learn More on Achieve Life Sciences's short interest ratio. What is a good short interest percentage for Achieve Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.83% of Achieve Life Sciences' floating shares are currently sold short. Is Achieve Life Sciences' short interest increasing or decreasing? Achieve Life Sciences saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 2,970,000 shares, an increase of 13.4% from the previous total of 2,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Achieve Life Sciences' short interest compare to its competitors? 8.83% of Achieve Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Achieve Life Sciences: Myriad Genetics, Inc. (9.31%), Emergent Biosolutions Inc. (15.39%), Rigel Pharmaceuticals, Inc. (12.09%), XOMA Royalty Corporation (1.54%), Lexicon Pharmaceuticals, Inc. (12.07%), Vanda Pharmaceuticals Inc. (8.62%), Verastem, Inc. (24.92%), Codexis, Inc. (7.84%), Agenus Inc. (12.18%), Ironwood Pharmaceuticals, Inc. (4.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Achieve Life Sciences stock? Short selling ACHV is an investing strategy that aims to generate trading profit from Achieve Life Sciences as its price is falling. ACHV shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Achieve Life Sciences? A short squeeze for Achieve Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACHV, which in turn drives the price of the stock up even further. How often is Achieve Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACHV, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies MYGN Short Squeeze EBS Short Squeeze RIGL Short Squeeze XOMA Short Squeeze LXRX Short Squeeze VNDA Short Squeeze VSTM Short Squeeze CDXS Short Squeeze AGEN Short Squeeze IRWD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACHV) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNvidia’s Huang: AI is going to need 100x more power12Nvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.